学科与关键词
关键词
EGFR C797SPatient-derived OrganoidTargeted Therapy
- Clinical Outcomes of Lung Cancer Patients Who Acquired EGFR T790M/in trans-C797S Mutations After Resistance to OsimertinibLu, C.; Zhou, Z.; Zheng, D.; He, Y.; Li, Y.; Wang, Z.; Zhong, W.; Zhang, X.; Wu, Y.; Zhou, Q.
- Patient-derived organoids to predict the drug response in locally advanced or metastatic lung cancer: A real-world study.Zhang, Chan-Yuan; Wang, Han-Min; Peng, Kai-Cheng; Chen, Ze-Xin; Su, Jun-Wei; Chen, Yuqing; Gao, Qing-Yun; Zhang, Shi-Ling; Xu, Chongrui; Su, Jian; Yan, Hong-Hong; Zhang, Xuchao; Chen, Hua-Jun; Yang, Jin-JiAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 2022-06-03 To 2022-06-07.
- Efficacy and safety of AZD3759 in previously untreated EGFR-mutant non-small cell lung cancer with central nervous system metastases in a multi-center, phase II umbrella trial (CTONG1702)Liu, S. Y. M.; Zhou, Q.; Lu, C.; Deng, J. Y.; Wang, Z.; Li, Y. S.; Zheng, M. M.; Xu, B. F.; Dong, X. R.; Du, Y. Y.; Cui, J. W.; Chu, Q.; Bai, X. Y.; Sun, Y. L.; Li, A.; Xu, C-R.; Wang, B. C.; Chen, H. J.; Yang, J. J.; Wu, Y. L.
